Hence, several repressors and activators of TSPAN8, such as GSK3β, IQGAP1, TPT1, LCMR1, PTEN, and p53, were recently identified in melanoma 46, 47 which could potentially be involved in the regulation of TSPAN8 expression in breast cancer. Here, MED19 is linked to breast carcinoma.